Evidence map›Paper›PMID 30234471›Full record

ArticleThe Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques2018

Canadian Assessment of Deep Brain Stimulation Access: The Canada Study.

C Michael Honey, Armaan K Malhotra, Mandeep S Tamber, Michel Prud'homme, Ivar Mendez, Christopher R Honey

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Mapping the Landscape of Equitable Access to Advanced Neurotechnologies in Canada.The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques · 2023
    Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

C Michael Honey1Department of Surgery,Section of Neurosurgery,University of Manitoba,Winnipeg,Manitoba,Canada.ORCID 0000-0002-2960-6255
Armaan K Malhotra2Faculty of Medicine,University of British Columbia,Vancouver,British Columbia,Canada.
Mandeep S Tamber3Department of Surgery,Division of Pediatric Neurosurgery,University of British Columbia,Vancouver,British Columbia,Canada.
Michel Prud'homme4Département des Sciences Neurologiques,CHU de Québec (Hôpital de l'Enfant-Jésus),Québec,Québec,Canada.
Ivar Mendez5Department of Surgery,College of Medicine,University of Saskatchewan,Saskatoon,Saskatchewan,Canada.
Christopher R Honey6Department of Surgery,Division of Neurosurgery,University of British Columbia,Vancouver,British Columbia,Canada.
University of British Columbia · CAUniversity of Saskatchewan · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Canada Health Act requires reasonable access to all medically necessary therapies. No information is available to assess the current access to neuromodulation across Canada. This study quantifies the current rate of deep brain stimulation (DBS) for the entire country of Canada. Analyses were performed to determine whether there were differences in access based on provincial or territorial location, rural or non-rural region, or socioeconomic status.

methodsAll implanted DBS devices in Canada over a 2-year epoch (January 2015 to December 2016) were supplied by either Boston Scientific or Medtronic. Investigators received anonymized data from these companies, including patient age and home residence region. The 2016 Statistics Canada census data were used to determine the rate of DBS surgery and whether access was related to provincial location, rural versus non-rural region or socioeconomic status.

resultsA total of 722 patients were studied. The rate of DBS surgery for the entire country was ten per million population per year. Saskatchewan was significantly above (374%) the national average, whereas Quebec (40%) and Newfoundland & Labrador (32%) were significantly below the national average. No patients from the three territories received DBS. There were no significant differences in access from rural versus non-rural areas or in regions within provinces with different socioeconomic status.

conclusionsThis is the first study to quantify all patients receiving DBS within an entire country. The current rate of DBS surgery within Canada is ten cases per million per year. Statistically significant regional differences were discovered and discussed.

Indexed as

Health Services AccessibilityBrain DiseasesCanadaDeep Brain StimulationFemaleGeographic MappingHumansLongitudinal StudiesMaleRetrospective StudiesRural PopulationUrban PopulationCanadaDeep brain stimulationHealth care accessNeuromodulationSocioeconomic status

Identifiers

PMID30234471
OpenAlexW2889742772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.